Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-09-08

FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) by Teva Respiratory, LLC, typically indicating an update to labeling or pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProAir Digihaler (albuterol sulfate)

Snippet

SUPPL AP for PROAIR DIGIHALER (ALBUTEROL SULFATE)